Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.

For analyses by prior cancer timing, although P values are significant or marginally significant for each comparison, the survival curves visually overlap and there is not a clinically meaningful difference ( Figure 3A ).

also in 26,082 other papers